Chris Lamb

Professor Chris Lamb is a faculty member at Newcastle University, specializing in Inflammatory Bowel Disease (IBD), Gut Microbiota, and Pharmacogenetics. His work focuses on optimizing clinical outcomes through microbiome research, precision medicine, and evidence-based guideline development for IBD management.

• Key research themes include colorectal cancer surveillance in IBD patients, biologic therapy effectiveness, and microbiota-driven disease mechanisms.
• Recent publications highlight advancements in intestinal tissue preservation methods, pharmacogenetic testing, and integrin-targeted therapies for postoperative Crohn's disease recurrence.

His collaborations span national and international studies, including the CLARITY IBD cohort and IBD-RESPONSE precision medicine initiative. While no formal awards or student lists are documented in the provided texts, his contributions to clinical guidelines and multicenter trials underscore his leadership in IBD research and practice.